Inventor

Gabriela Chiosis

Inventor
New York, NY, US

Overview

31→
Patents
2004–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 31 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes25%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
A61BDiagnosis3%
C07BGeneral methods of organic chemistry3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology1%
G16CComputational chemistry1%
PatentTitleYear
11,065,350HSP90-targeted inflammation and infection imaging and therapy202110,793,570Methods and reagents for radiolabeling202010,758,538Heat shock protein binding compounds, compositions, and methods for making and using same202010,676,476Small-molecule HSP90 inhibitors202010,647,683Hsp70 modulators and methods for making and using the same202010,617,772Hsp9O-targeted inflammation and infection imaging and therapy202010,421,758Selective Grp94 inhibitors and uses thereof201910,336,757Treatment of neurodegenerative diseases through inhibition of HSP90201910,329,293Methods and reagents for radiolabeling201910,201,623HSP90-targeted cardiac imaging and therapy201910,172,863Purine derivatives useful as HSP90 inhibitors201910,167,285Small-molecule HSP90 inhibitors201910,160,729Hsp70 modulators and methods for making and using the same201810,064,867Hsp90 inhibitors201810,052,325Heat shock protein binding compounds, compositions, and methods for making and using same201810,000,494Small-molecule Hsp90 inhibitors20189,994,573Methods and reagents for radiolabeling20189,926,321'Hsp90 inhibitors'20189,878,987'HSP70 modulators and methods for making and using the same'20189,701,678'Small-molecule HSP90 inhibitors'20179,567,318'Substituted pyrimidine compounds and uses thereof'20179,555,137'Uses of labeled HSP90 inhibitors'20179,546,170'Hsp90 inhibitors'20179,403,828'Small-molecule Hsp90 inhibitors'20169,346,808'Hsp90 inhibitors'20169,328,114'Hsp90 inhibitors'20168,703,942'Small-molecule Hsp90 inhibitors'20147,834,181'Small-molecule Hsp90 inhibitors'20107,439,359'Small molecule compositions for binding to hsp90'20086,953,861'Method of re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide'20056,734,165'Method for re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2021Based in New York, NY, US· patent location history
2008–2016Patents assigned to SLOAN KETTERING INST CANCER (4)· patent assignee history
2014–2019Patents assigned to CHIOSIS GABRIELA (8)· patent assignee history
2016–2017Patents assigned to TALDONE TONY (5)· patent assignee history
2017–2021Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (15)· patent assignee history
2018–2020Patents assigned to SLOAN KETTERING INST CANCER RES (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MEMORIAL SLOAN KETTERING CANCER CENTER152017–2021
CHIOSIS GABRIELAself82014–2019
SLOAN KETTERING INST CANCER RES62018–2020
TALDONE TONY52016–2017
SLOAN KETTERING INST CANCER42008–2016
Locations
LocationPatentsSpan
New York, New York, US312004–2021